First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 162.35 USD -2.95% Market Closed
Updated: Apr 26, 2024

Abbvie Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Cash Interest Paid Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Cash Interest Paid
$2.5B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash Interest Paid
$891m
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
Cash Interest Paid
$2.4B
CAGR 3-Years
26%
CAGR 5-Years
10%
CAGR 10-Years
10%
Moderna Inc
NASDAQ:MRNA
Cash Interest Paid
$39m
CAGR 3-Years
63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Interest Paid
$43.1m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Interest Paid
$73.1m
CAGR 3-Years
47%
CAGR 5-Years
27%
CAGR 10-Years
12%

See Also

What is Abbvie Inc's Cash Interest Paid?
Cash Interest Paid
2.5B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Cash Interest Paid amounts to 2.5B USD.

What is Abbvie Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
15%

Over the last year, the Cash Interest Paid growth was -3%. The average annual Cash Interest Paid growth rates for Abbvie Inc have been -2% over the past three years , 15% over the past five years .